Andrew D. Kelly

TET1-Mediated Hypomethylation Activates Oncogenic Signaling in Triple-Negative Breast Cancer

Charly R. Good, Shoghag Panjarian, Andrew D. Kelly et al. · Cancer Research · 2018 · 174 citations · Full text

Medicine, Molecular Biology, Oncology +17

MicroRNA paraffin-based studies in osteosarcoma reveal reproducible independent prognostic profiles at 14q32

Andrew D. Kelly, Benjamin Haibe‐Kains, Katherine A. Janeway et al. · Genome Medicine · 2013 · 118 citations · Full text

Medicine, Oncology, Pathology +17

Metabolomic Profiling from Formalin-Fixed, Paraffin-Embedded Tumor Tissue Using Targeted LC/MS/MS: Application in Sarcoma

Andrew D. Kelly, Susanne B. Breitkopf, Min Yuan et al. · PLoS ONE · 2011 · 77 citations · Full text

Life Sciences, Biochemistry, Cancer Biology +17

An imprinted non-coding genomic cluster at 14q32 defines clinically relevant molecular subtypes in osteosarcoma across multiple independent datasets

Katherine E. Hill, Andrew D. Kelly, Marieke L. Kuijjer et al. · Journal of Hematology & Oncology · 2017 · 42 citations · Full text

Medicine, Genetics, Oncology +17

MicroRNA-155 expression is independently predictive of outcome in chordoma

Eiji Osaka, Andrew D. Kelly, Dimitrios Spentzos et al. · Oncotarget · 2015 · 40 citations · Full text

Medicine, Oncology, Surgery +17